
Ayman Al-Hendy, MD, PhD and Maria Lopes, MD, MS discuss common concerns that women seek care for during their reproductive years, including uterine fibroids, endometriosis, and unintended pregnancy.
Ayman Al-Hendy, MD, PhD and Maria Lopes, MD, MS discuss common concerns that women seek care for during their reproductive years, including uterine fibroids, endometriosis, and unintended pregnancy.
Dr Lopes, OB-GYN and payer, discusses a focus on screening and prevention and availability of contraception among health plans in women’s health.
Steven McCarus, MD FACOG highlights the shift away from surgical treatment toward medical therapy in UF and endometriosis.
Kevin Stephens, Sr. MD, JD examines key drivers of healthcare utilization for women of childbearing years.
Ayman Al-Hendy, MD, PhD identifies risk factors for development of US and endometriosis.
Payer considerations regarding unintended pregnancy is discussed by Maria Lopes, MD, MS, and Kevin Stephens Sr., MD, JD.
Dr Steven McCarus discusses the journey of a patient with endometriosis through the health care system.
Dr Ayman Al-Hendy discusses the diagnosis of uterine fibroids and endometriosis along with treatment goals.
A panel of experts discuss treatment selection among contraceptive agents and evolving treatment strategies for uterine fibroids and endometriosis.
Payer decision-makers discuss defining value among agents for unintended pregnancy, uterine fibroids, and endometriosis.
The panel deliberates appropriate surgical intervention in women with uterine fibroids or endometriosis.
Key opinion leaders share their perspectives on utilization management strategies in treatment of women’s health.
Ryan Haumschild, PharmD, MBA, MS, provides background on the Affordable Care Act (ACA) within the scope of women’s health, including specific mandates on contraceptives.
A medical professional explains the many facets of the prior authorizations process for drugs in women’s health.
A payer discusses medical exceptions processes and triggers for a class review for drugs in women’s health, along with wraparound programs for uterine fibroids and endometriosis.
This expert panel considers an increasing collaborative effort between payers, patients, and providers for patient-centered care.
Panelists share their final insights on improving the trajectory for women’s health care.
259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512
© 2025 MJH Life Sciences®
All rights reserved.